-+ 0.00%
-+ 0.00%
-+ 0.00%

Wedbush Maintains Underperform on Praxis Precision Medicine, Raises Price Target to $83

Benzinga·12/05/2025 13:41:33
Listen to the news
Wedbush analyst Laura Chico maintains Praxis Precision Medicine (NASDAQ:PRAX) with a Underperform and raises the price target from $77 to $83.